Gene expression profiling of clinical stages II and III breast cancer

Gene expression profiling of clinical stages II and III breast cancer

Clinical stage (CS) is an established indicator of breast cancer outcome. In the present study, a cDNA microarray platform containing 692 genes was used to identify molecular differences between CSII and CSIII disease. Tumor samples were collected from patients with CSII or CSIII breast cancer, and...

Full description

Bibliographic Details
Main Authors: M.A.A.K. Folgueira, H. Brentani, M.L.H. Katayama, D.F.C. Patrão, D.M. Carraro, M. Mourão Netto, E.M. Barbosa, J.R.F. Caldeira, A.P.S. Abreu, E.C. Lyra, J.H.L. Kaiano, L.D. Mota, A.H.J.F.M. Campos, M.S. Maciel, M. Dellamano, O.L.S.D. Caballero, M.M. Brentani
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2006-08-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Breast cancer
cDNA microarray
Clinical stage
Gene expression
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000800013

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000800013

Similar Items